Frontlight ResearchEarly access
Trial site
UCLA Department of Medicine - Hematology/Oncology
- 15running trials
- 4closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Gastric and oesophageal cancer7 trials
- Ovarian cancer5 trials
- Bladder cancer4 trials
- Cervical cancer4 trials
- Pancreatic cancer4 trials
- Colorectal cancer3 trials
- Head and neck cancer3 trials
- Endometrial cancer2 trials
- Melanoma2 trials
- Metastatic breast cancer2 trials
- Multiple myeloma2 trials
- and 9 more
- Phase
- Phase 38 trials
- Phase 16 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Active, not recruiting7 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Pfizer5 trials
- Eli Lilly and Company2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Arcus Biosciences, Inc.1 trial
- Cardiff Oncology1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer4 recruiting
- Pancreatic cancer4 recruiting
- Head and neck cancer3 recruiting
- Lung cancer3 recruiting
- Ovarian cancer3 recruiting
- Bladder cancer2 recruiting
- Cervical cancer2 recruiting
- Prostate cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
- Metastatic breast cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026